NextCure  Inc

NASDAQ NXTC

Data sourced from iex and EODHD
Download Data

NextCure  Inc Income Statement 2018 - 2024

This table shows the Income Statement for NextCure  Inc going from 2018 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Revenue
M 0 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22 2 2 1 1 - - - -
Cost of Revenue
M 1 1 1 1 1 1 - - - - - - - - - - - 12 8 0 - - 5 0 -
Gross Profit
M -1 5 -1 -1 -1 -1 - - - - - - 0 0 - - 22 2 2 1 1 - -5 0 -
Operating Expenses
M 15 21 15 18 16 16 - - - - - - 17 16 - - 31 14 11 10 8 - 1 5 -
Selling, General, and Administrative Expenses (SG&A)
M 4 4 5 6 5 5 6 5 6 5 5 6 5 4 5 5 4 3 3 3 2 1 1 1 1
Research and Development (R&D) Expenses
M 11 12 11 13 12 13 14 13 15 12 14 12 12 12 13 11 11 11 9 8 7 6 5 4 4
Other Operating Expenses
M -1 5 -1 -1 -1 -1 - - - - - - 0 0 - - 16 0 0 0 0 - -5 0 -
Costs and Expenses
M 14 14 15 18 16 16 - - - - - - - - - - - 2 3 10 - - 1 5 -
Operating Income
M -16 -16 -16 -19 -17 -18 -19 -18 -21 -17 -19 -18 -17 -16 -17 -16 -8 -12 -10 -9 -7 -7 -6 -5 -5
Interest Expense
M - 1 - - 1 0 0 0 0 - - - - - - - - 0 0 0 0 - 0 0 0
Non-operating Income/Expense
M -1 1 1 1 1 0 0 0 0 0 1 0 1 1 1 1 2 1 1 1 1 0 0 0 0
EBT
M -17 -14 -14 -18 -16 -17 -19 -18 -21 -17 -18 -18 -17 -15 -16 -15 10 -11 -8 -8 -6 -7 -6 -5 -5
Income Tax Provision
M - 1 - - -1 0 0 0 0 - - - - - - - - - - - - - - - -
Income after Tax
M - -15 - - -15 -17 -19 -18 -20 - - - - - - - - - - - - - - - -
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0
Net Income
M - - - -18 -16 -17 -19 -18 -21 -17 -18 -18 -17 -15 -16 -15 10 -11 -8 -8 -6 - -6 -5 -5
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 27,903,040.00 27,909,980.00 27,839,968.00 27,828,741.00 27,774,536.00 27,744,209.00 27,748,844.00 27,744,762.00 27,708,768.00 27,615,038.00 27,615,038.00 27,610,398.00 27,597,426.00 27,547,737.00 27,547,737.00 27,518,129.00 29,348,615.00 27,506,927.00 22,715,567.00 13,498,393.00 21,935,381.00 10,038,582.00 10,038,582.00 10,038,582.00 10,038,582.00
EBITDA
M -15 -15 -15 -18 -16 -17 -18 -18 -19 -15 -16 -16 -16 -15 -17 -15 9 -11 -9 -8 -6 -7 -5 -5 -5
Depreciation and Amortization
M 1 1 1 1 1 1 1 0 2 2 2 2 1 1 1 1 1 1 1 1 1 1 0 0 0
EBIT
M -16 -16 -16 -19 -17 -18 -19 -18 -21 -17 -19 -18 -17 -16 -17 -16 8 -12 -10 -9 -7 -7 -6 -5 -5
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% - -6.74 - - 6.06 2.72 1.73 1.16 0.82 - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0
Gross Profit Margin
% - 86.89 - - - - - - - - - - - - - - 100.00 100.00 100.00 100.00 100.00 - - - -
Operating Income Margin
% - -251.27 - - - - - - - - - - - - - - -36.70 -599.00 -612.89 -638.73 -502.21 - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - 43.49 -544.99 -532.79 -586.38 -453.57 - - - -
EBITDA Ratio
% - -238.16 - - - - - - - - - - - - - - 40.05 -561.35 -563.11 -597.22 -460.72 - - - -
EBIT Ratio
% - -251.27 - - - - - - - - - - - - - - 36.70 -599.00 -612.89 -638.73 -502.21 - - - -
EBT Ratio
% - -230.22 - - - - - - - - - - - - - - 43.49 -544.99 -532.79 -586.38 -453.57 - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email